InvestorsHub Logo
Followers 53
Posts 1775
Boards Moderated 0
Alias Born 03/22/2015

Re: Money_Tree post# 149579

Tuesday, 03/31/2015 10:32:23 PM

Tuesday, March 31, 2015 10:32:23 PM

Post# of 400013
I wasn't thinking about it like that.


So you're saying the intermediate release oxy will gain bigger market share than oxycontin?




I think the intermediate-release would wiggle into the middle and take market share from both oxyIR and oxyContin.

How about this-- Elite keeps ELI-200 as its flagship product (love that dryer!) and then licenses ELI-201 (ADT-OxyContin) to anyone and everyone who agrees to our price. Multiple companies do all the manufacturing and send us a monthly % check. Elite licenses ELI-216 (24 hour ADT-oxy) to the one highest bidder. Same deal, huge upfront $$ and % of total sales, no manufacturing cost.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News